Survey: More Than Half of Women in States with Abortion Bans Wouldn’t Know Where to Get an Abortion if They Needed One, Up Since 2024
More than half (53%) of reproductive-age women living in states with abortion-provision bans say they…
More than half (53%) of reproductive-age women living in states with abortion-provision bans say they would not know where to go or where to find information if they needed an abortion, up from 43% in 2024, according to a new KFF survey.
This brief provides national estimates from the 2026 KFF Women’s Health Survey on reproductive age women’s experiences with abortion, the impact of Dobbs on abortion access and women’s concerns about future pregnancies, as well as women’s knowledge on the availability of medication abortion.
Corxel Pharmaceuticals is catching up to others with oral GLP-1 obesity drugs, but the biotech claims its small molecule could offer better tolerability compared to the rest of its class. The SPAC merger taking Corxel public is expected to close in the first half of 2027, which is when the biotech plans to start a…
ONC estimates the rule will save more than $1.5 billion in regulatory costs while retaining key privacy, security, patient safety, accessibility and interoperability requirements
Sutter Health, a nonprofit healthcare system based in Sacramento, California, is expanding its digital chronic disease management program, Sutter Sync, to include patients with heart failure. The expansion adds a remote monitoring technology from San Francisco-based medical tech company BodyPort. The program expansion comes as health systems look for ways to identify deterioration in a…
At the 2026 WEDI National Conference, HSCC task group co-leads Bill Reid and Ed Gaudet outlined a practical approach to AI governance that addresses cybersecurity, clinical risk, vendor dependencies and resilience.
HHS plan details several potential ways to create a more competitive dialysis market
CMS has introduced uncertainty about whether Medicare will participate in that modernization or preserve the old system under a different name. The consequences extend far beyond billing The post In a Maternity Care Crisis, CMS Undermines Efforts To Modernize Care appeared first on MedCity News.
[Sponsored] For US biotech companies developing rare disease therapies, decisions about clinical evidence, patient populations and regulatory advice can have consequences in Europe long before a marketing application is submitted. The post FDA Alignment Is a Starting Point, Not a Rare Disease Strategy for the European Market appeared first on MedCity News.
Dianne Williams said she lost weight and lowered her blood pressure thanks to quarterly doctor appointments, monthly phone calls with a nurse, and a blood pressure cuff she uses at home that transmits data to her care team. “It’s good to have somebody talk to you and tell you what your progress is like. And…